The Head of the Department for the Study of Biological Effects and Application of Lasers in Ophthalmology at the Filatov Institute of Eye Diseases and Tissue Therapy, Andriy Korol, told the Interfax-Ukraine agency about the prospects of using artificial intelligence technologies in medicine.
Paris, France, March 27, 2024 – Coave Therapeutics (‘Coave’), a genetic medicine company focused on developing life-changing therapies, announces that its management will be attending the following upcoming investor and industry conferences: Cell & Gene Meeting on the Med – April 9-11 ; Rome, ItalyCompany Presentation by CEO Rodolphe Clerval on April 10 at 13.45 CET LSX World Congress – April 29-30 ; London, UKCEO Rodolphe Clerval attending and available for investor meetings BioEquity Europe –
In a crowded thyroid eye disease (TED) space, Innovent Biologics Inc. reported positive late-stage findings for its TED therapy, IBI-311, spurring the Suzhou, China-based biopharma to file for regulatory approval in China.
Hydroquinine, a compound found in some trees, could be an effective and naturally occurring disinfecting solution to help combat diseases such as keratitis